Abiomed's Impella(R) Technology Showcased at TCT 2015 With Over 25 Presentations in the Scientific Sessions

Published on:
DANVERS, Mass., Oct. 08, 2015 (GLOBE NEWSWIRE) -- Abiomed Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, announces that there are currently over 25 presentations potentially featuring the Impella line of heart pumps, scheduled in the scientific sessions at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) 2015 scientific meeting, scheduled from October 11 - 15, at the Moscone Convention Center in San Francisco. On the TCT show floor, at Abiomed’s booth #1117 there will be daily demonstrations and opportunities for physicians to engage in hands-on simulations of the Impella platform with new simulator technology. Additionally, Abiomed anticipates the broadcast of potentially multiple live cases utilizing Impella from the participating live case sites in the main arena, coronary theater and structural heart theater in the Moscone Center.  Further details concerning these live cases will be disclosed the day of the scheduled procedures, as patient status is subject to change.  About AbiomedBased in Danvers, Massachusetts, Abiomed, Inc., is a leading provider of medical devices that provide circulatory support. Our products are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. For additional information please visit: www.abiomed.com.

Related Content

Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access
FDA clears AI screening tool for cardiac amyloidosis
IVUS-guided PCI reduces risks in patients with diabetes
SCCT leaders unpack the 2025 Medicare payment increase for coronary CTA
Global shortage of nuclear imaging isotopes may be over
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."